GSK’s FIRST-ENGOT-OV44 phase III clinical trial of Zejula and Jemperl in first line advanced ovarian cancer meets primary endpoint: London Saturday, December 21, 2024, 09:00 Hrs ...
Tech4Good Awards 2024 showcased AI’s role in advancing healthcare in India, with AIIMS and Wadhwani Institute recognized for their contributions. AI technologies are improving early cancer diagnosis ...